Article
Levofloxacin 1.5% concentration combats ocular pathogens
Fort Lauderdale, FL-Topical levofloxacin 1.5% (Santen), a new concentration of the drug in clinical development, achieves tear-fluid concentrations well above the reported minimum inhibitory concentrations (MIC) for the most common ocular pathogens, reported Tom R. Walters, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Related Videos
Related Content
Published: December 19th 2024 | Updated: December 19th 2024
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
